Pluto Bioinformatics

GSE101540: RNA-seq of cancer cell lines treated with T-025

Bulk RNA sequencing

4 cancer cell lines were treated with T-025 for 6 hours; T-025 is a novel small molecule inhibitor of CLK. CLK is a kinase that regulates pre-mRNA splicing. SOURCE: Kenichi Iwai TAKEDA pharaceutical comapny